Citadel Advisors’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.53M Buy
113,071
+29,652
+36% +$2.18M ﹤0.01% 3471
2025
Q4
$5.66M Buy
83,419
+67,429
+422% +$4.21M ﹤0.01% 4094
2025
Q3
$912K Sell
15,990
-67,389
-81% -$3.99M ﹤0.01% 7736
2025
Q2
$4.62M Buy
+83,379
New +$3.91M ﹤0.01% 4250
2025
Q1
Sell
-1,601
Closed -$69.8K 14632
2024
Q4
$68.9K Buy
1,601
+365
+30% +$16.4K ﹤0.01% 11995
2024
Q3
$55.2K Buy
+1,236
New +$51.1K ﹤0.01% 11799
2024
Q2
Sell
-16,152
Closed -$556K 14421
2024
Q1
$556K Sell
16,152
-13,064
-45% -$419K ﹤0.01% 8140
2023
Q4
$846K Sell
29,216
-8,183
-22% -$187K ﹤0.01% 7005
2023
Q3
$708K Buy
+37,399
New +$710K ﹤0.01% 7312

Other funds holding DBD

Citadel Advisors's DBD Position: Q1 2026 in Review

Citadel Advisors increased its Diebold Nixdorf (DBD) stake by 36% in Q1 2026, buying an estimated $2.18M and bringing the position to 113,071 shares worth $8.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

Citadel Advisors first reported a position in DBD in Q3 2023 and has held it in 9 quarters since. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • Citadel Advisors held 113,071 shares of Diebold Nixdorf worth $8.53M as of Q1 2026.
  • Citadel Advisors bought 29,652 Diebold Nixdorf shares in Q1 2026, an estimated $2.18M.
  • Diebold Nixdorf made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3471 holding.
  • Citadel Advisors first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 9 quarters since.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.